
Eventide Healthcare & Life Sciences A
ETAHX
Updated: 24/09/2026, 22:53:44
Under typical market conditions, this fund commits a substantial portion—at least 80%—of its total investable capital (net assets plus any borrowed funds for investment) to equity and equity-linked instruments. These holdings specifically target companies within the healthcare and life sciences sectors, encompassing a range of securities such as common shares, preferred stock, options, and convertible debt. Furthermore, the fund possesses the flexibility to acquire stakes in companies domiciled outside the United States, without any geographical restrictions. This can be done either directly or through American Depositary Receipts (ADRs). Its investment mandate also allows for the inclusion of companies across the entire spectrum of market capitalizations, from small-cap to large-cap firms.
No summaries found.
- Share price
- $53.51
- Market cap
- $1.78B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 27/12/2012
- Beta
- 1.01
- Last dividend
- $0.00
- Day range
- $53.51 – $53.51
- 52-week range
- $39.14 – $60.18
- 1-day performance
- -4.14%
- 1-year performance
- 36.71%
- Current drawdown (1Y)
- -11.08%
- CIK
- 0001355064
- CUSIP
- 62827M409
- ISIN
- US62827M4096
- Created
- 07/12/2025, 03:50:30
- Last update
- 24/09/2026, 22:53:44
Track Eventide Healthcare & Life Sciences A with an AI analyst
See which prediction-market events move ETAHX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.